{"id":"W2114300639","doi":"10.1200/jco.2005.13.011","title":"Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":421,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"University of Washington","keywords":"Medicine; Hazard ratio; Lung cancer; Internal medicine; Toxicity; Cyclophosphamide; Performance status; Stage (stratigraphy); Randomized controlled trial; Chemotherapy; Surgery; Gastroenterology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008072216,0.0002231098,0.003144987,0.0003031449,0.00005569764,0.000007312295,0.00032643,0.0007790358,0.0008919094],"category_scores_gemma":[0.002171006,0.0001581037,0.00064262,0.0001416937,0.0003787761,0.000160858,0.0000799883,0.001307381,0.000009655413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007869663,"about_ca_system_score_gemma":0.00116387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000110784,"about_ca_topic_score_gemma":0.00009635145,"domain_scores_codex":[0.9924592,0.002841149,0.004064919,0.0002161287,0.00006894455,0.000349636],"domain_scores_gemma":[0.9899589,0.006725397,0.002821314,0.0002188384,0.0002155851,0.00005997106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8742368,0.003770659,0.0007026247,0.00002836231,0.0008414722,0.0000370571,0.0004441751,0.00002328654,0.04241437,0.00003541315,0.000764797,0.07670099],"study_design_scores_gemma":[0.9206285,0.008909231,0.001303646,0.0001007258,0.0003811261,0.00006301734,0.0001391749,0.00006666389,0.01033785,0.00002615574,0.05788682,0.0001570997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9629112,0.03122281,0.0001039436,0.002349119,0.002262645,0.0006890835,0.00001100796,0.000006020308,0.0004441544],"genre_scores_gemma":[0.9715778,0.02308348,0.0003440671,0.000749669,0.0004476806,0.00002248594,0.000003671871,0.00002010216,0.003751004],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07654388,"threshold_uncertainty_score":0.9765782,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05074711381612095,"score_gpt":0.4307104094668897,"score_spread":0.3799632956507687,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}